According to Sun Pharma, the purpose of the strategic investment is to obtain access to the technology for certain compounds and territories while also fostering the development of novel pharmaceutical delivery systems.
from IIFL Securities https://ift.tt/Uh94wgV
via IFTTT
For $30 million, Sun Pharma will purchase 16.7% of Lyndra Therapeutics
December 19, 2023
0
Tags
